AR024671A1 - Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos - Google Patents

Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos

Info

Publication number
AR024671A1
AR024671A1 ARP000103465A ARP000103465A AR024671A1 AR 024671 A1 AR024671 A1 AR 024671A1 AR P000103465 A ARP000103465 A AR P000103465A AR P000103465 A ARP000103465 A AR P000103465A AR 024671 A1 AR024671 A1 AR 024671A1
Authority
AR
Argentina
Prior art keywords
ylcarbonyl
piperazinyl
formula
hal
benzofuran
Prior art date
Application number
ARP000103465A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR024671A1 publication Critical patent/AR024671A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Derivados de benzofurano de formula (1) en donde R representa 1-piperazinilo, 4-R1piperazinilo o L, R representa 2-R2-5-R3-pirrol-1-ilcarbonilo, 4-R4-piperazin-1-ilcarbonilo, N, N-di(terbutiloxicarbonil)aminocarbonilo, -CH=C(R5R6), benzofuran-2-il-C. ..C-, -C(Hal)3,-CO-C(Hal)3,1,4-dihidrobenzo[d][1,2]oxazin-3-ilcarbonilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilcarbonilo, L representa Cl, Br, I o un grupo OH libre o funcionalmente modificado en un grupo reactivo, R1, R4representan cada cualindependien temente, H, bencilo u otro grupo protector de amino, R2, R3 representan, cada cual independientemente, H, o alquilo C1-6R5, R6 representan cada cual independientemente, alquilo C1-6, Hal representa F, Cl, Br o I, y las sales de estoscompuestos. Unpr ocedimiento para preparar los derivados del benzofurano de formula (1) en el cual a) para preparar compuestos de formula (1) en la cual R representa Cl, Br,I, 1-piperazinilo o 4-R1-piperazinilo, y R representa 2-R2-5-R3-pirrol-1-ilcarbonilo, 4-R4-pip erazin-1-ilcarbonilo, 1,4-dihidrobenzo [d][1,2]-oxazin-3-ilcarbonilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilcarbonilo, se hace reaccionar un compuesto de formula (2) en donde R representa Cl, Br, I, 1-piperazinilo o4-R1-piperazinilo y Q representa Cl, Br , I o un grupo OH libre o funcionalmente modificado en un grupo reactivo, y R1 tiene el significado indicado en lareivindicacion 1, con un compuesto de formula R-H en donde R representa 2-R2-5-R3-pirrol-1-ilo, 4-R4-piperazin-1-ilo, 1,4-dihidrobenzo [d][1,2]- oxazin-3-ilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilo, y R2, R3 y R4 tienen los significados indicados en la reivindicacion 1, o b) para preparar compuestos de formula (1),en la cual R representa Cl, Br, I,1-piperazinilo o 4-R1-piperazinilo, y R representa -CH=C(R5R6), benzofuran-2-il-C...C, -C(Hal)3 o -CO-C(Hal)3, y R1, R5 yR6 tienen los significados indicados en la reivindicacion 1, i) se hace reaccionar un compuesto de la formula (3) en donde Rrepresenta Cl, Br, I, 1-piperazinilo o 4- R1-piperazinilo con un compuesto de formula: Q-CH2-CO-R en donde R representa -CH=C(R5R6), benzofuran-2-il-C...C-, -C(Hal)3 o -CO-C(Hal)3, y
ARP000103465A 1999-07-10 2000-07-07 Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos AR024671A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19932314A DE19932314A1 (de) 1999-07-10 1999-07-10 Benzofuranderivate

Publications (1)

Publication Number Publication Date
AR024671A1 true AR024671A1 (es) 2002-10-23

Family

ID=7914351

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103465A AR024671A1 (es) 1999-07-10 2000-07-07 Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos

Country Status (29)

Country Link
US (1) US6531503B1 (es)
EP (1) EP1194426B1 (es)
JP (1) JP4908706B2 (es)
KR (1) KR100709378B1 (es)
CN (1) CN1178934C (es)
AR (1) AR024671A1 (es)
AT (1) ATE273973T1 (es)
AU (1) AU767413B2 (es)
BR (1) BRPI0012329B8 (es)
CA (1) CA2378603C (es)
CZ (1) CZ301441B6 (es)
DE (2) DE19932314A1 (es)
DK (1) DK1194426T3 (es)
ES (1) ES2226884T3 (es)
HK (1) HK1047275B (es)
HU (1) HU229135B1 (es)
IL (2) IL147494A0 (es)
MX (1) MXPA02000316A (es)
MY (1) MY122667A (es)
NO (1) NO328209B1 (es)
PL (1) PL196477B1 (es)
PT (1) PT1194426E (es)
RU (1) RU2278862C2 (es)
SI (1) SI1194426T1 (es)
SK (1) SK287360B6 (es)
TR (1) TR200200017T2 (es)
UA (1) UA73310C2 (es)
WO (1) WO2001004112A2 (es)
ZA (1) ZA200201085B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006060597A1 (de) * 2006-12-21 2008-06-26 Merck Patent Gmbh Verfahren zur Herstellung von Benzofuran-2-carboxamiden
EP2110374A1 (en) * 2008-04-18 2009-10-21 Merck Sante Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
UY32481A (es) * 2009-03-10 2010-09-30 Takeda Pharmaceutical Derivados de benzofurano
WO2011140161A1 (en) 2010-05-06 2011-11-10 Bristol-Myers Squibb Company Benzofuranyl analogues as gpr119 modulators
US8940716B2 (en) 2010-05-06 2015-01-27 Bristol-Myers Squibb Company Bicyclic heteroaryl compounds as GPR119 modulators
CN102964323B (zh) * 2012-11-13 2015-03-25 苏州永健生物医药有限公司 一种5-(哌嗪-1-基)苯并呋喃-2-甲酰胺的合成方法
US9428501B2 (en) * 2013-06-10 2016-08-30 Astellas Pharma Inc. Bicyclic nitrogen-containing aromatic heterocyclic amide compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2724915A (en) * 1955-11-29 Snow remover
DE2757532A1 (de) * 1977-12-23 1979-07-05 Hoechst Ag N,n'-disubstituiertes cyclisches diamin und verfahren zu dessen herstellung
DE69404039T2 (de) * 1993-06-14 1997-10-16 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19514567A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Benzofurane

Also Published As

Publication number Publication date
NO20020095L (no) 2002-01-09
SK62002A3 (en) 2002-05-09
WO2001004112A2 (de) 2001-01-18
JP2003504364A (ja) 2003-02-04
ZA200201085B (en) 2003-07-30
US6531503B1 (en) 2003-03-11
UA73310C2 (en) 2005-07-15
BRPI0012329B8 (pt) 2021-05-25
DK1194426T3 (da) 2004-12-20
ES2226884T3 (es) 2005-04-01
AU767413B2 (en) 2003-11-06
HK1047275A1 (en) 2003-02-14
HUP0201903A2 (en) 2002-10-28
EP1194426B1 (de) 2004-08-18
KR20020016815A (ko) 2002-03-06
HU229135B1 (en) 2013-08-28
KR100709378B1 (ko) 2007-04-20
SK287360B6 (sk) 2010-08-09
CA2378603A1 (en) 2001-01-18
AU6266500A (en) 2001-01-30
CN1178934C (zh) 2004-12-08
CA2378603C (en) 2010-05-11
CZ301441B6 (cs) 2010-03-03
PL196477B1 (pl) 2008-01-31
MXPA02000316A (es) 2002-07-30
EP1194426A2 (de) 2002-04-10
SI1194426T1 (en) 2005-02-28
DE50007501D1 (de) 2004-09-23
RU2278862C2 (ru) 2006-06-27
TR200200017T2 (tr) 2002-05-21
JP4908706B2 (ja) 2012-04-04
NO20020095D0 (no) 2002-01-09
BR0012329A (pt) 2002-03-19
HUP0201903A3 (en) 2005-02-28
HK1047275B (zh) 2005-09-02
MY122667A (en) 2006-04-29
ATE273973T1 (de) 2004-09-15
IL147494A (en) 2008-03-20
WO2001004112A3 (de) 2001-08-02
NO328209B1 (no) 2010-01-11
IL147494A0 (en) 2002-08-14
PT1194426E (pt) 2005-01-31
CZ200211A3 (cs) 2002-04-17
PL353157A1 (en) 2003-10-20
CN1356996A (zh) 2002-07-03
DE19932314A1 (de) 2001-01-11
BR0012329B1 (pt) 2013-03-19

Similar Documents

Publication Publication Date Title
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
DE69010139D1 (de) Haarkräftigungsmittel.
MY114679A (en) Aroyl-piperidine derivatives
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
PT1086124E (pt) Ciclosporinas novas
CA2011346A1 (en) 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
BR0108677A (pt) Novos compostos
UY27368A1 (es) Nuevos compuestos
CA2054619A1 (en) Aminocoumaran derivatives, their production and use
WO1998035951A3 (en) New aminopiperazine derivatives
FR2442845A1 (fr) Derives amines spiranniques, leur preparation et leur utilisation comme medicaments
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
GEP19960656B (en) Method for production of phenylalkylamines or its pharmaceutically acceptable salts
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
EP0353955A3 (en) Novel compounds
DE60011462D1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
BR9814055A (pt) Composto, composição farmacêutica, processo para o tratamento de uma doença alérgica, uso do composto, e, processos para preparar e para produzir um composto
AR024671A1 (es) Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos
BR0309558A (pt) Derivados de quinazolina e medicamentos
BR0112043A (pt) Ftalidas substituìdas, processo para sua preparação e composições farmacêuticas contendo-as
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
CA2436438A1 (en) 4-aminobenzopyran derivatives
HUP0301551A2 (hu) 5-HT3 és idegi nikotinsav receptor antagonista 1-amino-alkil-ciklohexán származékok új alkalmazása

Legal Events

Date Code Title Description
FG Grant, registration